Press releases
- Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024
- Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
- Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
Key statistics
On Friday, Brii Biosciences Ltd (7SS:FRA) closed at 0.141, 35.58% above the 52 week low of 0.104 set on Apr 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.146 |
---|---|
High | 0.146 |
Low | 0.141 |
Bid | 0.142 |
Offer | 0.157 |
Previous close | 0.142 |
Average volume | 461.20 |
---|---|
Shares outstanding | 729.81m |
Free float | 587.57m |
P/E (TTM) | -- |
Market cap | 890.37m HKD |
EPS (TTM) | -0.2594 HKD |
Data delayed at least 15 minutes, as of Jun 07 2024 14:29 BST.
More ▼